Results 231 to 240 of about 52,751,136 (335)

Mastering CT-based radiomic research in lung cancer: a practical guide from study design to critical appraisal. [PDF]

Br J Radiol
Horne A, Abravan A, Fornacon-Wood I, O'Connor JPB, Price G, McWilliam A, Faivre-Finn C.   +6 more
europepmc   +1 more source

DESIGN AND MASS TRANSFER STUDY FOR NEW MULTISTAGE FLUIDIZATION REACTOR (thesise

, 1960
K.D. Jr. Williamson
openalex   +2 more sources

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) - study design of a prospective cohort study. [PDF]

Int J Bipolar Disord
Bayas M, Kockler TD, Ramos-Quiroga JA, Caller SM, Fadeuilhe C, de Girolamo G, Iozzino L, D'Addazio M, Haavik J, Halmøy A, Hellum KS, Kolle JN, Osnes B, Lundervold AJ, Perroud N, Hasler R, De Almeida MT, Ebner-Priemer UW, Thanarajah SE, Schiweck C, Matura S, Repple J, Reif A, Aichholzer M.   +23 more
europepmc   +1 more source

DESIGN STUDIES ON CESIUM-137 AS A SOURCE FOR HIGH LEVEL GAMMA IRRADIATORS. Quarterly Progress Report No. 3 Covering the Period from December 1, 1959 to March 1, 1960

, 1960
L. Voyvodie
openalex   +2 more sources

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview. [PDF]

Dermatol Ther (Heidelb)
Ingram JR, Kokolakis G, McGrath BM, Romanelli M, Bechara FG, Martorell A, Biermann M, Geissbühler Y, Haeberle BM, Zahid M, Fritz M, Quebe-Fehling E, Richardson C, Becherel PA.   +13 more
europepmc   +1 more source

DESIGN STUDY OF PORTABLE THERMOELECTRIC NUCLEAR SYSTEMS

, 1961
L. Chajson, A.R. DelCampo, H.B. Kellogg
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

PROFiling patients’ healthcare needs to support integrated, person-centered models for Long-term disease management (PROFILe): Study design and rationale

International Journal of Integrated Care, 2015
Dorijn F.L. Hertroijs, Arianne M.J. Elissen, Nicolaas Schaper, Dirk Ruwaard   +3 more
doaj   +1 more source